Table 3.
Group | 0 | 1 | 2 | 3 | 4 | χ2 | |
Steatosis | Control | 10 | 0 | 0 | 0 | ||
Model A | 0 | 1 | 3 | 7 | 17.6b | ||
Model B | 0 | 1 | 1 | 9 | 18.4b 7.51d | ||
Inflammatory score | Control | 10 | 0 | 0 | 0 | ||
Model A | 3 | 3 | 1 | 4 | 17.3b | ||
Model B | 2 | 4 | 0 | 5 | 17.2b 4.9c | ||
Cytologic ballooning | Control | 9 | 1 | 0 | 0 | 0 | |
Model A | 0 | 5 | 6 | 0 | 0 | 10.8b | |
Model B | 0 | 3 | 8 | 0 | 0 | 11.1b | |
Perisinusoidal fibrosis | Control | 10 | 0 | 0 | 0 | 0 | |
Model A | 0 | 8 | 3 | 0 | 0 | 17.9b | |
Model B | 0 | 7 | 4 | 0 | 0 | 17.6b | |
Overall fibrosis | Control | 10 | 0 | 0 | 0 | ||
Model A | 5 | 6 | 0 | 0 | 17.5b | ||
Model B | 4 | 7 | 0 | 0 | 17.6b |
Compared with control, aP < 0.05,
P < 0.01. Compared with model A,
P < 0.05,
P < 0.01.